Seagen Inc (SGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4301FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Seagen Inc (SGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Seagen Inc (Seagen), formerly Seattle Genetics Inc, is a biotechnology company that discovers, develops and markets monoclonal antibody-based therapies for the treatment of cancer. It markets antibody-drug conjugates (ADCs) including Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma, T-cell lymphomas, and CD30-expressing lymphomas; and Padcevtm (enfortumab vedotin-ejfv) to treat metastatic urothelial cancers. The company’s pipeline consists of novel therapies that for addressing the unmet medical needs of blood-related cancers and solid tumors. Seagen products and pipeline are based on ADC technology that targets monoclonal antibodies and delivers agents for killing cancer cells. The company sells its products through specialty distributors. Seagen is headquartered in Bothell, Washington, the US.

Seagen Inc Key Recent Developments

Feb 24,2021: Seagen to Present at the Cowen 41st Annual Healthcare Conference
Feb 11,2021: Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
Nov 09,2020: Seagen highlights immuno-oncology data from broad portfolio during SITC Virtual Annual Meeting 2020
Oct 29,2020: Seagen reports third quarter 2020 financial results
Oct 08,2020: Seattle Genetics announces corporate name change to Seagen

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Seagen Inc – Key Facts
Seagen Inc – Key Employees
Seagen Inc – Key Employee Biographies
Seagen Inc – Major Products and Services
Seagen Inc – History
Seagen Inc – Company Statement
Seagen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Seagen Inc – Business Description
Business Segment: Collaboration and License Agreement Revenue
Performance
Business Segment: Net Product Sales
Performance
Business Segment: Royalty Revenues
Performance
R&D Overview
Seagen Inc – Corporate Strategy
Seagen Inc – SWOT Analysis
SWOT Analysis – Overview
Seagen Inc – Strengths
Seagen Inc – Weaknesses
Seagen Inc – Opportunities
Seagen Inc – Threats
Seagen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Seagen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: Seagen to Present at the Cowen 41st Annual Healthcare Conference
Feb 11, 2021: Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
Nov 09, 2020: Seagen highlights immuno-oncology data from broad portfolio during SITC Virtual Annual Meeting 2020
Oct 29, 2020: Seagen reports third quarter 2020 financial results
Oct 08, 2020: Seattle Genetics announces corporate name change to Seagen
Aug 27, 2020: Seattle Genetics highlights data from broad oncology portfolio during ESMO Virtual Congress 2020
Aug 18, 2020: Seattle Genetics appoints Ted W. Love, M.D., to Board of Directors
Jul 30, 2020: Seattle Genetics reports second quarter 2020 financial results
May 13, 2020: Seattle Genetics highlights data from expanding oncology portfolio during virtual scientific program of the 2020 ASCO annual meeting
Apr 30, 2020: Seattle Genetics reports first quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Seagen Inc, Key Facts
Seagen Inc, Key Employees
Seagen Inc, Key Employee Biographies
Seagen Inc, Major Products and Services
Seagen Inc, History
Seagen Inc, Subsidiaries
Seagen Inc, Key Competitors
Seagen Inc, Ratios based on current share price
Seagen Inc, Annual Ratios
Seagen Inc, Annual Ratios (Cont...1)
Seagen Inc, Interim Ratios
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Seagen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Seagen Inc (SGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pets at Home Group Plc.:企業の戦略・SWOT・財務分析
    Pets at Home Group Plc. - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ICON Plc (ICLR)-製薬・医療分野:企業M&A・提携分析
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • NovaMedica LLC-製薬・医療分野:企業M&A・提携分析
    Summary NovaMedica LLC is a drug company that offers gastroenterology and ophthalmology products. The company offers pharmaceutical and other medical products such as diagnostic equipment, medical devices and technologies designed to provide a solution for range of interrelated problems. It provides …
  • Hovnanian Enterprises Inc:企業の戦略・SWOT・財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Gas y Petroleo del Neuquen SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas y Petroleo del Neuquen SA (Gas Y Petroleo) operates as an oil and gas exploration company. It is engaged in the production and supply of hydrocarbon resources. The company holds 36 contracts with other companies, to develop exploratory and hydrocarbon exploitation activities. It is also …
  • Nippon Yusen Kabushiki Kaisha:企業の戦略・SWOT・財務情報
    Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Global Geophysical Services Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Global Geophysical Services Inc (Global Geophysical) is an oil and gas company that offers geophysical technology solutions. The company offers consulting; reservoir grade 3D data sets and land and marine seismic acquisition; seismic data processing; geophysical, geological and engineering s …
  • Atkins Ltd:企業の戦略・SWOT・財務情報
    Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nisshin Seifun Group Inc:企業の戦略・SWOT・財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Teijin Limited:企業の戦略・SWOT・財務分析
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AB Volvo:戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SPX Corporation:企業の戦略・SWOT・財務分析
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NYU Langone Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary NYU Langone Medical Center (NYU LMC) a subsidiary of New York University School of Medicine is an academic healthcare center that provides patient care, education and research services. The center offers patient care services such as patient and family support; imaging services, medical serv …
  • Foamix Pharmaceuticals Ltd (FOMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • Randstad Holding nv:企業のM&A・事業提携・投資動向
    Randstad Holding nv - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randstad Holding nv Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MedEquities Realty Trust, Inc. (MRT):企業の財務・戦略的SWOT分析
    MedEquities Realty Trust, Inc. (MRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Minoryx Therapeutics sl-製薬・医療分野:企業M&A・提携分析
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company provides discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysoso …
  • Myriad Genetics Inc (MYGN):企業の製品パイプライン分析2018
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Volex plc (VLX):企業の財務・戦略的SWOT分析
    Volex plc (VLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆